Biliary tract cancer is a type of cancer that affects the organs and structures of the biliary system, which is responsible for producing and excreting bile. This system is made up of the gallbladder, bile ducts, and the liver. The most common type of biliary tract cancer is cholangiocarcinoma, which begins in the cells of the bile ducts. Other types of biliary tract cancer include gallbladder cancer, ampulla of Vater cancer, and hepatocellular carcinoma (HCC). Risk factors for biliary tract cancer include cirrhosis, chronic inflammation of the bile ducts, primary sclerosing cholangitis, and a genetic predisposition. People with certain inherited conditions, such as familial adenomatous polyposis and Gardner syndrome, may also be at increased risk. Symptoms of biliary tract cancer include jaundice, abdominal pain, weight loss, and fatigue. Other symptoms may include itching, dark-colored urine, and pale stools. Diagnosis is usually made through imaging tests and biopsy. Treatment for biliary tract cancer often involves surgery, radiation therapy, and/or chemotherapy. In some cases, targeted therapy and immunotherapy may be used. The prognosis for biliary tract cancer depends on the stage and location of the cancer, as well as the patient’s overall health. Early detection and treatment can improve the chances of a successful outcome.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China